For assistance completing this form, please call TOGETHER with TESARO at 1-844-2TESARO (1-844-283-7276) Monday through Friday (8 AM to 8 PM ET). TOGETHER with TESARO™ Program Enrollment Application 5Clinical Information
Full Answer
What is the Teva Cares Foundation?
The Teva Cares Foundation provides patient assistance programs created to make a positive difference in the lives of patients, families and local communities. For decades, Teva has been working through its Patient Assistance Programs to improve patient access to medication and ensure that cost is not a barrier to treatment.
Is there a patient assistance program for Teva medications?
Teva’s commitment to patients provides certain Teva medications at no cost to patients in the United States who meet certain insurance and income criteria. Please click here to review the list of medications available through the Teva Cares Foundation Patient Assistance Program (PAP), or call 877-237-4881.
Why choose Tersera Therapeutics?
Our focus is to bring intelligent solutions to prescribers and patients who need better solutions. We deliver a comprehensive set of programs that go beyond the therapy itself in order to provide improved outcomes for patients. For more information about TerSera Therapeutics, please contact us.
What's new at Tersera®?
TerSera® Announces Publication of Real-World Study on Xermelo® (Telotristat Ethyl) in Patients with Carcinoid Syndrome Diarrhea TerSera® Presents Data on Cetirizine HCl Injection (QUZYTTIR®) in the Prevention of Hypersensitivity Infusion Reactions in Patients with Breast Cancer and Other Malignancies
How to contact Tersera Therapeutics?
Is Tersera responsible for third party websites?
VARUBI Coupons | Up to an 80% discount on prescription medication
Always pay a fair price for your medication! Our FREE VARUBI discount coupon helps you save money on the exact same VARUBI prescription you're already paying for. Print the coupon in seconds, then take it to your pharmacy the next time you get your VARUBI prescription filled.
Drug Approvals and Databases | FDA
CDER highlights key Web sites. Web page provides quick links to everything from acronyms to wholesale distributor and third-party logistics providers reporting. Additional topics include: approved ...
Varuby | European Medicines Agency
Product information documents contain:. summary of product characteristics (annex I);; manufacturing authorisation holder responsible for batch release (annex IIA); conditions of the marketing authorisation (annex IIB);; labelling (annex IIIA);; package leaflet (annex IIIB).; You can find product information documents for centrally authorised human medicines on this website.
IMPORTANT DRUG WARNING IMPORTANT PRESCRIBING INFORMATION ...
TESARO, Inc. │1000 Winter Street, Suite 3300 │Waltham, MA 02451 January 2018 IMPORTANT DRUG WARNING IMPORTANT PRESCRIBING INFORMATION Subject: Anaphylaxis, anaphylactic shock and other serious
rolapitant (Varuby) - SMC
On 13 December 2019, Tesaro ceased the commercialization of rolapitant (as hydrochloride monohydrate) 90mg film-coated tablets (Varuby).The decision to cease commercialization is not due to efficacy, safety or public health issues.
Midazolam - Food and Drug Administration
4 99% of the mixture is present in the closed-ring form. Midazolam Injection, USP pharmacy bulk package is a sterile solution dosage form for preparing intravenous (IV) or intramuscular (IM) injections.
Products
Our products make a difference for patients and provide solutions for prescribers. To learn more, please follow the links below to visit the individual product websites or view the Full U.S. Prescribing Information, including Boxed Warning where applicable. To report an adverse event or side effect call 1-844-334-4035
Interested in learning more about TerSera Therapeutics?
Click here for easy access to full product and prescribing information for all our marketed medicines. To reach out directly, please refer to the contact information below.
U.S. Healthcare Professionals
If your patient qualifies for assistance from OPAF, the next step is for you to submit an application on their behalf.
Have Questions About OPAF and Don't Have Time for a Phone Call?
Send a secure message directly to a Dedicated OPAF Patient Case Coordinator.
Co-pay Assistance
Eligible commercially insured patients could pay as little as $0 for their medicine. Download and complete the Together with GSK Oncology enrollment form with your patient to submit for approval. Terms and Conditions apply.
Patient Assistance Program (PAP)
Uninsured patients who meet eligibility requirements may access medication free of charge through the GSK Patient Assistance Program (PAP) offered by the GSK PAP Foundation. Medicare patients who meet program requirements may also be eligible for the Patient Assistance Program. Check Eligibility.
Patient Assistance Program Eligibility Calculator
The GSK Patient Assistance Program (PAP) offered by the GSK PAP Foundation has residential, insurance, and income eligibility requirements. This calculator can help determine whether your patient might be eligible.
Sample Payer Letters
Together with GSK Oncology cannot submit letters on behalf of physicians or patients, however we have included sample letters that you can customize based on the patient’s condition and the requirements of the plan.
Co-pay Assistance Eligibility Check
To enroll your patients in the Together with GSK Oncology Co-pay Program, you or the specialty pharmacy should complete the information through the link below.
Quick Start and Bridge Program
For patients experiencing delay in coverage at first dispense (Quick Start), or coverage interruptions while already on treatment (Bridge), download and fill out the enrollment form then fax to Together with GSK Oncology at 1-800-645-9043 to check for eligibility.
Savings & Support
Explore the dedicated support your patients will receive throughout their treatment journey with ZEJULA.
How to contact Tersera Therapeutics?
To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.FDA.gov/medwatch. You may also contact TerSera Therapeutics at 1-913-647-6204 or [email protected].
Is Tersera responsible for third party websites?
TerSera provides this link as a service to website visitors. TerSera is not responsible for the privacy policy of any third-party website.